Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

12/10

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

09/10

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

08/10

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together…

First HIV-positive to HIV-negative liver transplant raises intriguing questions for cure research

21/10

An HIV-negative child received a liver transplant from its HIV-positive mother and now appears to have no evidence of HIV…

ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

18/10

Priority review voucher used with NDA submission with anticipated target action date of six months London, UK 17 October 2018…

Studies confirm long-term effectiveness of new single-tablet regimens

18/10

The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a…

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

12/10

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

09/10

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

08/10

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together…

First HIV-positive to HIV-negative liver transplant raises intriguing questions for cure research

21/10

An HIV-negative child received a liver transplant from its HIV-positive mother and now appears to have no evidence of HIV…

ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

18/10

Priority review voucher used with NDA submission with anticipated target action date of six months London, UK 17 October 2018…

Studies confirm long-term effectiveness of new single-tablet regimens

18/10

The newest once-daily, all-in-one HIV combination pills can maintain undetectable viral load for two years and counting, according to a…